Fresh analysis indicates that people who come off popular weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass much more quickly than those who stop conventional diet and exercise regimens.
Published data in a prominent health publication demonstrates that while obese individuals frequently drop a large proportion of their total mass while using the jabs, the weight comes back at an average rate of 0.8 kg per month after stopping.
"Users buying these drugs need to be informed of the danger of quick rebound weight gain when the treatment concludes," warns researcher Dr. Susan Jebb.
This pace of regain implies a return to pre-treatment weight within about 18 months.
Comparing Approaches
The analysis, which reviewed dozens of trials involving over 9,000 of participants, contrasted the outcomes of GLP-1 agonists with other pills.
The team emphasize that individuals who shed pounds through lifestyle changes alone usually have a less rapid weight regain—around 0.1 kg a month—after stopping.
Explaining the Fast Regain
Experts propose the way of the injections explains the accelerated rebound.
These medications imitate a natural hormone called GLP-1, which controls feelings of fullness.
"Sustained high doses of the hormone concentrations far above than normal might result in the body to produce less of its own natural hormone, and could diminish responsiveness to its actions," noted Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this medication leads to appetite is unsuppressed, making overeating far more likely."
A Chronic Issue?
Health authorities advise the injections for individuals with obesity-related health risks, alongside prescribed diet and exercise modifications.
A number of clinicians say that, due to the high risk of weight regain, the treatment should be considered life-long.
This opinion is supported by drug manufacturers, who note that the findings "emphasize the long-term nature of obesity," akin to managing conditions like high blood pressure.
User Testimonies
Individuals who have stopped the medication explain a powerful resurgence of cravings.
"I experienced a switch flipping and you become extremely hungry," said an individual.
This challenge is exacerbated if individuals have not established sustainable lifestyle or habit modifications during treatment.
Significant Interest
Figures show that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with desire remaining high.
- Use is more common among women compared to men.
- The middle-aged age group shows the highest level of interest.
- Many access the drugs through private healthcare rather than public health services.
Ultimately, experts stress that while these medications are potent tools for shedding pounds, they are not a magic cure and lasting health benefits hinges on integrated behavioural support.
